Interphex Presents a Wide Array of Packaging Innovations

Author(s)Hallie Forcinio

The latest developments in packaging technology made a strong showing at the 2001 Interphex exhibition.

External Link - article-5140.pdf

Articles in this issue

about 25 years ago

Article

Report on the Industry Blend Uniformity Practices Survey

about 25 years ago

Article

Changes and Challenges for CDER

Newsletter

Get the essential updates shaping the future of pharma manufacturing and compliance. Subscribe to Pharmaceutical Technology and never miss an industry breakthrough.

Subscribe

Related Content

Pharma Fundamentals: Risks and Regulations for Hold Times in Biopharmaceuticals

ByRobert Dream,Susan Haigney

August 27th 2026

3D bioprinting is the utilization of 3D printing to combine cells, growth biomaterials to make biomedical parts | Image Credit: ©luchschenF -stock.adobe.com

3D Printing Revolutionizing Tissue Engineering and Regenerative Medicine in Europe

ByCheryl Barton

August 26th 2026

McKesson Corporation agreed to acquire Precision Medicine Group, adding a variety of drug development and commercialization capabilities.

What the McKesson-Precision Medicine Deal Signals for Trial Sponsors

ByZachary Zubulake

August 25th 2026

n-nitrosodimethylamine molecular structure, 3d model molecule, dimethylnitrosamine, structural chemical formula view from a microscope | Image Credit: ©Сергей Шиманович -stock.adobe.com

From Detection to Prediction: Modern Analytical Approaches for Nitrosamine Risk

ByChris Williams

August 24th 2026

Genglycos (pariglasgene brecaparvovec-opnr), a gene therapy for adult and pediatric patients eight years and older with glycogen storage disease type Ia recieved accelerated approval from the FDA.

GSDIa Gene Therapy Approval Signals New Path for Rare Disease Manufacturing

ByZachary Zubulake

August 20th 2026

Interphex Presents a Wide Array of Packaging Innovations

Articles in this issue

Related Content

Pharma Fundamentals: Risks and Regulations for Hold Times in Biopharmaceuticals

3D Printing Revolutionizing Tissue Engineering and Regenerative Medicine in Europe

What the McKesson-Precision Medicine Deal Signals for Trial Sponsors

From Detection to Prediction: Modern Analytical Approaches for Nitrosamine Risk

GSDIa Gene Therapy Approval Signals New Path for Rare Disease Manufacturing

Trending on Pharmaceutical Technology

Rasonque's 60% Survival Benefit: What It Means for Oncology Pipelines

3D Printing Revolutionizing Tissue Engineering and Regenerative Medicine in Europe

What the McKesson-Precision Medicine Deal Signals for Trial Sponsors

Pharma's Next AI Problem Is Authority

GSK's Jemperli Rectal Cancer Filing Signals Biologics Capacity Shift